BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 4943915)

  • 1. Drug treatment in newly admitted schizophrenic patients.
    Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
    Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
    [No Abstract]   [Full Text] [Related]  

  • 2. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
    Altman H; Mehta D; Evenson RC; Sletten IW
    J Am Geriatr Soc; 1973 Jun; 21(6):241-8. PubMed ID: 4575803
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 5. High- and low-potency neuroleptics in elderly psychiatric patients.
    Branchey MH; Lee JH; Amin R; Simpson GM
    JAMA; 1978 May; 239(18):1860-2. PubMed ID: 347110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
    Martin IC
    Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and work performance variables in phenothiazine therapy of schizophrenia.
    Chacon C; Harper P
    Acta Psychiatr Scand; 1973; 49(1):65-76. PubMed ID: 4572169
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of some possible prognostic indicators of response to phenothiazine treatment of acute schizophrenic psychoses.
    Reznikoff M; Toomey LC
    Int J Neuropsychiatry; 1965 Aug; 1(4):352-8. PubMed ID: 4379396
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of improvement in schizophrenia under four phenothiazines.
    Goldberg SC; Mattsson N; Cole JO; Klerman GL
    Arch Gen Psychiatry; 1967 Jan; 16(1):107-17. PubMed ID: 6066689
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Fluphenazine with other antipsychotic drugs.
    Chouinard G; Fontaine R
    Am J Psychiatry; 1975 Jul; 132(7):760-1. PubMed ID: 1137032
    [No Abstract]   [Full Text] [Related]  

  • 11. Are antipsychotic drugs interchangeable?
    Gardos G
    J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
    [No Abstract]   [Full Text] [Related]  

  • 12. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
    Guo GY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced dystonia.
    Swett C
    Am J Psychiatry; 1975 May; 132(5):532-4. PubMed ID: 1119613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
    van Praag HM; Dols LC
    Am J Psychiatry; 1973 Jul; 130(7):801-4. PubMed ID: 4576449
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 16. EEG voltage as an indicator of drug-induced changes in schizophrenia.
    Bruck MA
    Am J Psychiatry; 1968 May; 124(11):1591-5. PubMed ID: 4869441
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of antipsychotic drugs on memory functions of schizophrenic patients.
    Eitan N; Levin Y; Ben-Artzi E; Levy A; Neumann M
    Acta Psychiatr Scand; 1992 Jan; 85(1):74-6. PubMed ID: 1347670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluphenazine in the long term treatment of psychoses. A preliminary communication.
    Gunby B; Brun H; Hartviksen I
    Acta Psychiatr Scand Suppl; 1968; 203():225-30. PubMed ID: 4881876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.